Fosun medicine: the new crown vaccine has been included in the domestic phase II clinical, and no serious adverse report has been received

Bid for Molecular Tech in China's Early-Stage Cancer Detection Market

China, with a population of 1.4 billion, has one of the largest gene pools in the world. How does its DNA tech-based cancer detection industry look? Listed on Nasdaq in 2020, Genetron Holdings Limited (Genetron Health) is taking a leading role. 

Sinopharm COVID Vaccine Receives WHO Emergency Use Certification

The Sinopharm Group’s COVID Vaccine is the sixth vaccine to receive safety, efficacy and quality verification from the World Health Organization (WHO). It is the first vaccine from a non-Western country to receive WHO certification.

Yunnan Baiyao's Revenue Rises 33%; Net Profit Falls 40% in 1Q 2021

On April 27, Yunnan Baiyao released a report for the first quarter of 2021 showing that the company's total operating revenue for the first quarter was 10.33 billion yuan, up 33.4% year-on-year; its operating profit was 880 million yuan, down 41.8% year-on-year; its net profit attributable to shareholders of the listed company was 760 million yuan.

StoneWise Technology Raises over USD 100 Mn in Series B and Series B+

The pioneering AI molecular drug design platform is growing and is expected to support its further research with the funds.

Revenue and Net Profit of Wuxi Apptec Both Increased in 2020

Wuxi apptec said that the main reasons for the company's performance growth were the high growth of laboratories in China and the year-on-year growth of CDMO plate. China laboratory service is the core business of Wuxi apptec, accounting for more than 50% of its revenue. Its main business is small molecule drug discovery, drug analysis and testing.